Prix Optimi Health Corp. (OPTHF)

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.